Clinical Trial

Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye

Study acronym: EXOIUMS
Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 1, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine the safety and efficacy of Limbal Stem Cells derived Exosomes (LSC-Exo) in alleviation of dry eye symptoms
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-04; most recent amendment 2025-04-30.
Trial Details
NCT Number NCT06543667
Lead Sponsor Iran University of Medical Sciences
Conditions Dry Eye Syndromes
Enrollment 30 participants
Start Date 2024-08-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-01